AI-Powered smartwatches hunt for stealthy heart condition in stroke survivors

NCT ID NCT07540065

Not yet recruiting Diagnosis Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using artificial intelligence (AI) along with a smartwatch and a heart monitor patch can find a hidden heart rhythm problem called atrial fibrillation (AF) in people who have had a stroke. AF can cause strokes, but it often comes and goes without symptoms. The trial will compare this AI-assisted approach to standard follow-up care in 400 stroke patients. If it works, it could help doctors start blood-thinning medicine sooner to prevent another stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-guided workflow with smartwatch and ECG patch
What this could lead to: If successful, this could make it easier to detect hidden heart rhythm problems after a stroke, helping doctors start blood thinners earlier to prevent another stroke.
What could go wrong: This trial hasn't started yet, and it's testing a new way of using existing devices. The AI may not improve detection rates as hoped, and the smartwatch or patch might be uncomfortable or unreliable for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICIAL INTELLIGENCE ATRIAL FIBRILLATION STROKE

Contacts and locations

Locations

National Taiwan University Hospita

Taipei, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.